Ceryvyn Therapeutics Limited (ASX:CYV)
0.0110
0.00 (0.00%)
Nov 20, 2026, 4:10 PM AEDT
Ceryvyn Therapeutics Market Cap
Ceryvyn Therapeutics has a market cap or net worth of 15.05 million as of November 19, 2026. It is the 40,971st most valuable company in the world and the 1,133rd biggest in Australia. Its market cap has decreased by 97.96% in one year.
Market Cap
15.05M
Enterprise Value
-14.97M
Revenue
1.00K
Global Rank
Country Rank
#1,133 Australia
PE Ratio
0.04
ChartMarket Cap Chart
Since May 13, 1996, Ceryvyn Therapeutics's market cap has decreased from 39.30M to 15.05M, a decrease of -61.71%. That is a compound annual growth rate of -3.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 15.05M | -98.49% |
| Dec 31, 2024 | 997.31M | 163.98% |
| Dec 29, 2023 | 377.80M | -11.57% |
| Dec 30, 2022 | 427.23M | -6.26% |
| Dec 31, 2021 | 455.76M | -29.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Algorae Pharmaceuticals | 18.25M |
| Miro Sciences | 16.76M |
| Proteomics International Laboratories | 15.55M |
| Imugene | 15.18M |
| ReNerve | 13.96M |
| EZZ Life Science Holdings | 13.65M |
| Patrys | 13.39M |
| Radiopharm Theranostics | 13.01M |